New pill tested to fight sickle cell disease
NCT ID NCT05169580
Summary
This early-stage study tested the safety and effects of an experimental oral medication called FTX-6058 in adults with sickle cell disease. Forty-five participants took the daily pill for 12 weeks while researchers monitored for side effects and measured how the drug affected their blood. The main goal was to find a safe dose and see if the drug could increase protective fetal hemoglobin, which may help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barau Dikko Teaching Hospital
Kaduna, 800125, Nigeria
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
-
Charlotte Maxeke Johannesburg Academic Hospital
Johannesburg, 2193, South Africa
-
Eastern Carolina University
Greenville, North Carolina, 27834, United States
-
Inova Schar Cancer Institute
Fairfax, Virginia, 22031, United States
-
Jacobi Medical Center
The Bronx, New York, 10461, United States
-
Lynn Health Science Institute
Oklahoma City, Oklahoma, 73112, United States
-
National Hospital, Abuja
Abuja, 900247, Nigeria
-
Our Lady of the Lake Hospital
Baton Rouge, Louisiana, 70808, United States
-
Queens Hospital Cancer Center
Jamaica, New York, 11432, United States
-
Sonar Research Center
Atlanta, Georgia, 30315, United States
-
University of Arkansas for Medical Sciences (UAMS)
Little Rock, Arkansas, 72205, United States
-
University of California, Los Angeles
Los Angeles, California, 90095, United States
-
University of Ibadan
Ibadan, 200212, Nigeria
-
University of Illinois Chicago
Chicago, Illinois, 60612, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
University of Texas Houston
Houston, Texas, 77030, United States
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
Conditions
Explore the condition pages connected to this study.